Cargando…

Clinical Value of Sampling Time of Metagenomic Next-Generation Sequencing in Patients with Severe Pneumonia

OBJECTIVE: Severe pneumonia is a common infectious disease with high morbidity and mortality. Early etiological diagnosis is crucial for improving the prognosis. The aim of this study is to evaluate the clinical value of sampling time of mNGS in patients with severe pneumonia. METHODS: This retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shixiao, Zhou, Peng, Yang, Lihong, Tang, Tianbin, Qin, Jiajia, Qian, Jiao, Bo, Shen, Yu, Sufei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437727/
https://www.ncbi.nlm.nih.gov/pubmed/37601559
http://dx.doi.org/10.2147/IDR.S424185
_version_ 1785092598553116672
author Li, Shixiao
Zhou, Peng
Yang, Lihong
Tang, Tianbin
Qin, Jiajia
Qian, Jiao
Bo, Shen
Yu, Sufei
author_facet Li, Shixiao
Zhou, Peng
Yang, Lihong
Tang, Tianbin
Qin, Jiajia
Qian, Jiao
Bo, Shen
Yu, Sufei
author_sort Li, Shixiao
collection PubMed
description OBJECTIVE: Severe pneumonia is a common infectious disease with high morbidity and mortality. Early etiological diagnosis is crucial for improving the prognosis. The aim of this study is to evaluate the clinical value of sampling time of mNGS in patients with severe pneumonia. METHODS: This retrospective study enrolled 105 patients with severe pneumonia. mNGS was performed on bronchoalveolar lavage fluid (BALF). Patients were divided into the sampling time ≤ 72h vs sampling time >72h groups and survivors vs non-survivors groups according to their sampling time and prognosis. Clinical characteristics, the adjustment of antibiotics and clinical prognostic value were evaluated. RESULTS: Our study showed that, early sampling of mNGS can significantly shorten the mechanical ventilation time (p = 0.007) and hospitalization time (p = 0.004). In the non-survivors group, CURB-65, SOFA, and APACHE II scores were higher. Age (OR: 1.051, 95% CI: 1.004–1.100, p = 0.034), chronic respiratory diseases (OR: 4.639, 95% CI: 1.260–17.082, p = 0.021), immunosuppression (OR: 5.008, 95% CI: 1.617–15.510, p = 0.005) and SOFA score on the day of mNGS sampling (OR: 1.492, 95% CI: 1.212–1.837, p < 0.001) were independent risk factors of in-hospital mortality. The most common pathogens were Klebsiella pneumoniae and Human gammaherpesvirus 4. The proportion of appropriate and targeted antibiotics adjusted was significantly higher than that in the sampling time > 72h group, and the proportion of antifungal and antiviral agents adjusted was lower. In the early sampling group, it was significantly decreased in the CRP, PCT level and NEU% at discharge. CONCLUSION: This study demonstrated that early sampling of mNGS could shorten the time of mechanical ventilation and hospitalization of patients with severe pneumonia. Patients with higher SOFA score on the day of sampling had a poorer prognosis. It emphasizes that early sampling of mNGS has a positive value.
format Online
Article
Text
id pubmed-10437727
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104377272023-08-19 Clinical Value of Sampling Time of Metagenomic Next-Generation Sequencing in Patients with Severe Pneumonia Li, Shixiao Zhou, Peng Yang, Lihong Tang, Tianbin Qin, Jiajia Qian, Jiao Bo, Shen Yu, Sufei Infect Drug Resist Original Research OBJECTIVE: Severe pneumonia is a common infectious disease with high morbidity and mortality. Early etiological diagnosis is crucial for improving the prognosis. The aim of this study is to evaluate the clinical value of sampling time of mNGS in patients with severe pneumonia. METHODS: This retrospective study enrolled 105 patients with severe pneumonia. mNGS was performed on bronchoalveolar lavage fluid (BALF). Patients were divided into the sampling time ≤ 72h vs sampling time >72h groups and survivors vs non-survivors groups according to their sampling time and prognosis. Clinical characteristics, the adjustment of antibiotics and clinical prognostic value were evaluated. RESULTS: Our study showed that, early sampling of mNGS can significantly shorten the mechanical ventilation time (p = 0.007) and hospitalization time (p = 0.004). In the non-survivors group, CURB-65, SOFA, and APACHE II scores were higher. Age (OR: 1.051, 95% CI: 1.004–1.100, p = 0.034), chronic respiratory diseases (OR: 4.639, 95% CI: 1.260–17.082, p = 0.021), immunosuppression (OR: 5.008, 95% CI: 1.617–15.510, p = 0.005) and SOFA score on the day of mNGS sampling (OR: 1.492, 95% CI: 1.212–1.837, p < 0.001) were independent risk factors of in-hospital mortality. The most common pathogens were Klebsiella pneumoniae and Human gammaherpesvirus 4. The proportion of appropriate and targeted antibiotics adjusted was significantly higher than that in the sampling time > 72h group, and the proportion of antifungal and antiviral agents adjusted was lower. In the early sampling group, it was significantly decreased in the CRP, PCT level and NEU% at discharge. CONCLUSION: This study demonstrated that early sampling of mNGS could shorten the time of mechanical ventilation and hospitalization of patients with severe pneumonia. Patients with higher SOFA score on the day of sampling had a poorer prognosis. It emphasizes that early sampling of mNGS has a positive value. Dove 2023-08-14 /pmc/articles/PMC10437727/ /pubmed/37601559 http://dx.doi.org/10.2147/IDR.S424185 Text en © 2023 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Shixiao
Zhou, Peng
Yang, Lihong
Tang, Tianbin
Qin, Jiajia
Qian, Jiao
Bo, Shen
Yu, Sufei
Clinical Value of Sampling Time of Metagenomic Next-Generation Sequencing in Patients with Severe Pneumonia
title Clinical Value of Sampling Time of Metagenomic Next-Generation Sequencing in Patients with Severe Pneumonia
title_full Clinical Value of Sampling Time of Metagenomic Next-Generation Sequencing in Patients with Severe Pneumonia
title_fullStr Clinical Value of Sampling Time of Metagenomic Next-Generation Sequencing in Patients with Severe Pneumonia
title_full_unstemmed Clinical Value of Sampling Time of Metagenomic Next-Generation Sequencing in Patients with Severe Pneumonia
title_short Clinical Value of Sampling Time of Metagenomic Next-Generation Sequencing in Patients with Severe Pneumonia
title_sort clinical value of sampling time of metagenomic next-generation sequencing in patients with severe pneumonia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437727/
https://www.ncbi.nlm.nih.gov/pubmed/37601559
http://dx.doi.org/10.2147/IDR.S424185
work_keys_str_mv AT lishixiao clinicalvalueofsamplingtimeofmetagenomicnextgenerationsequencinginpatientswithseverepneumonia
AT zhoupeng clinicalvalueofsamplingtimeofmetagenomicnextgenerationsequencinginpatientswithseverepneumonia
AT yanglihong clinicalvalueofsamplingtimeofmetagenomicnextgenerationsequencinginpatientswithseverepneumonia
AT tangtianbin clinicalvalueofsamplingtimeofmetagenomicnextgenerationsequencinginpatientswithseverepneumonia
AT qinjiajia clinicalvalueofsamplingtimeofmetagenomicnextgenerationsequencinginpatientswithseverepneumonia
AT qianjiao clinicalvalueofsamplingtimeofmetagenomicnextgenerationsequencinginpatientswithseverepneumonia
AT boshen clinicalvalueofsamplingtimeofmetagenomicnextgenerationsequencinginpatientswithseverepneumonia
AT yusufei clinicalvalueofsamplingtimeofmetagenomicnextgenerationsequencinginpatientswithseverepneumonia